EWTX Overview
Upcoming Projects (EWTX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (EWTX)
-
A Third Opinion: Understanding the Phase 2 CIRRUS-HCM Clinical Trial Data on EDG-7500 for Hypertrophic Cardiomyopathy
Tickers: EWTX, CYTK, BMS
Executed On: Apr 10, 2025 at 11:00 AM EDT -
A Second Opinion: Understanding the Phase 2 CIRRUS-HCM Clinical Trial Data on EDG-7500 for Hypertrophic Cardiomyopathy
Tickers: EWTX, CYTK, BMS
Executed On: Apr 08, 2025 at 12:15 PM EDT -
Understanding the Phase 2 CIRRUS-HCM Clinical Trial Data on EDG-7500 for Hypertrophic Cardiomyopathy
Tickers: EWTX, CYTK, BMS
Executed On: Apr 04, 2025 at 10:30 AM EDT -
Discussing Sevasemten, a fast myofiber (type II) myosin inhibitor currently in Phase 2 studies from Edgewise Therapeutics for BMD.
Ticker: EWTX
Executed On: Jan 08, 2025 at 06:00 PM EST -
A Third Look: Speaking on the data to date on EDG-7500 for oHCM
Ticker: EWTX
Executed On: Oct 24, 2024 at 08:30 AM EDT -
Another Look: Speaking on the data to date on EDG-7500 for oHCM
Ticker: EWTX
Executed On: Oct 03, 2024 at 04:15 PM EDT -
Speaking on the data to date on EDG-7500 for oHCM
Ticker: EWTX
Executed On: Oct 01, 2024 at 04:45 PM EDT
Upcoming & Overdue Catalysts (EWTX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (EWTX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
